Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Oktober 2012

Planlagt Fastgjort Låst Flyttet Genmab
505 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • D Offline
    D Offline
    deleted-user
    wrote on sidst redigeret af
    #476

    men trenden er jo entydig god. Og det bliver jo trods alt sværere at vækste 15% hvert Q on Q

    1 Reply Last reply
    0
    • D Offline
      D Offline
      deleted-user
      wrote on sidst redigeret af
      #477

      men hvad der ikke funky bizz med det subcutane ??

      1 Reply Last reply
      0
      • S Offline
        S Offline
        Sukkeralf
        wrote on sidst redigeret af
        #478

        sirukumab gives subcutant. Ofatumumab er også gået over til sucutant i MS, men tror RA delen ligger stille.

        1 Reply Last reply
        0
        • SolsenS Offline
          SolsenS Offline
          Solsen
          wrote on sidst redigeret af
          #479

          MS alene er et 6-8 MIA USD marked mener jeg at huske - så det er ok i første omgang

          1 Reply Last reply
          0
          • D Offline
            D Offline
            deleted-user
            wrote on sidst redigeret af
            #480

            tak @sukkeralf

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Sukkeralf
              wrote on sidst redigeret af
              #481

              Det må være data fra dette studie GSK/Genmab venter på:

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Sukkeralf
                wrote on sidst redigeret af
                #482

                301 Moved Permanently

                favicon

                (www.clinicaltrials.gov)

                1 Reply Last reply
                0
                • D Offline
                  D Offline
                  deleted-user
                  wrote on sidst redigeret af
                  #483

                  så blev jeg klogere igen

                  1 Reply Last reply
                  0
                  • SolsenS Offline
                    SolsenS Offline
                    Solsen
                    wrote on sidst redigeret af
                    #484

                    http://pharma.about.com/od/Sales_and_Marketing/tp/Top-Multiple-Sclerosis-Drugs.htm

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Sukkeralf
                      wrote on sidst redigeret af
                      #485

                      Primary completion date: december 2012

                      1 Reply Last reply
                      0
                      • MadsSkjernM Offline
                        MadsSkjernM Offline
                        MadsSkjern
                        wrote on sidst redigeret af
                        #486

                        Spændende om det giver lige så gode resultater som iv. - Iøvrigt et stort fase2 studie 196 patienter kørt igennem på et år!

                        1 Reply Last reply
                        0
                        • troldmandenT Offline
                          troldmandenT Offline
                          troldmanden
                          wrote on sidst redigeret af
                          #487

                          så længe de stadig rekrutere patietner så kommer der tidligst resultater om 10 mdr.

                          1 Reply Last reply
                          0
                          • SolsenS Offline
                            SolsenS Offline
                            Solsen
                            wrote on sidst redigeret af
                            #488

                            Worldwide sales of Teva's treatment for multiple sclerosis, Copaxone, rose 12% to $982 million for the second quarter from $877 million for the corresponding quarter, accounting for half of Teva's brand drug sales and a fifth of its total sales

                            1 Reply Last reply
                            0
                            • SolsenS Offline
                              SolsenS Offline
                              Solsen
                              wrote on sidst redigeret af
                              #489

                              TEVA sælger alene for 4 mia USD i MS

                              1 Reply Last reply
                              0
                              • SolsenS Offline
                                SolsenS Offline
                                Solsen
                                wrote on sidst redigeret af
                                #490

                                Monster marked over 10 MIA USD

                                1 Reply Last reply
                                0
                                • SolsenS Offline
                                  SolsenS Offline
                                  Solsen
                                  wrote on sidst redigeret af
                                  #491

                                  Blot 10% til ofa og det giver 200 kurspoint ...

                                  1 Reply Last reply
                                  0
                                  • SolsenS Offline
                                    SolsenS Offline
                                    Solsen
                                    wrote on sidst redigeret af
                                    #492

                                    Dreaming :
                                    -)

                                    1 Reply Last reply
                                    0
                                    • D Offline
                                      D Offline
                                      deleted-user
                                      wrote on sidst redigeret af
                                      #493

                                      i like it

                                      1 Reply Last reply
                                      0
                                      • D Offline
                                        D Offline
                                        deleted-user
                                        wrote on sidst redigeret af
                                        #494

                                        jeg har ikke noget problem med at øge min position rimeligt kraftigt igen, hvis tallene fortsætter

                                        1 Reply Last reply
                                        0
                                        • investor1989I Offline
                                          investor1989I Offline
                                          investor1989
                                          wrote on sidst redigeret af
                                          #495

                                          Genmabben er monster spændende. Men salgstallene skal lige sive ind hos analytikere. Det er jo ikke sådan noget tryk på knappen ligeså snart de får mailen. De store skal altid lige afveje alting før de går igang

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger